Detecting adverse drug reactions on paediatric wards: Intensified surveillance versus computerised screening of laboratory values

Drug Safety

Volumn 28, Issue 5, 2005, Pages 453-464

  Haffner, Steffen ^a   Von Laue, Nicoletta ^a   Wirth, Stefan ^a   Thürmann, Petra A ^a,b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b HELIOS KLINIKUM WUPPERTAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CEFOTAXIME; CEFUROXIME; CREATININE; DIGITOXIN; DIGOXIN; ERYTHROMYCIN; ETHOSUXIMIDE; GENTAMICIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SULTAMICILLIN; THEOPHYLLINE; VALPROIC ACID; VANCOMYCIN;

ADVERSE DRUG REACTION; ANAPHYLAXIS; ANEMIA; ARTICLE; BLOOD DYSCRASIA; CANDIDIASIS; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONSTIPATION; DIARRHEA; DRUG MONITORING; DYSKINESIA; EDEMA; EOSINOPHILIA; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GERMANY; HEALTH CARE SYSTEM; HEALTH SURVEY; HEPATOMEGALY; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; INFANT; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LABORATORY TEST; LEUKOPENIA; LIVER INJURY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PREDICTION; PRIORITY JOURNAL; RASH; SCREENING; SKIN DISEASE; TACHYCARDIA; THROMBOCYTOPENIA; THROMBOCYTOSIS; VOMITING;

CHILD; CHILD, PRESCHOOL; COMPUTERS; DATA COLLECTION; DRUG THERAPY; FEMALE; GERMANY; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LABORATORIES, HOSPITAL; MALE; POPULATION SURVEILLANCE; SEVERITY OF ILLNESS INDEX;

EID: 19544383794     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200528050-00008     Document Type: Article

References (43)

1. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-11
2. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-6
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5
4. Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in pediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83
5. McKenzie MW, Stewart RB, Weiss CF, et al. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898-903
6. Whyte J, Greenan E. Drug usage and adverse drug reactions in pediatric patients. Acta Paediatr Scand 1977; 66: 767-75
7. Mitchell AA, Goldman P, Shapiro S, et al. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196-204
8. Choonara IA, Harris F. Adverse drug reactions in medical inpatients. Arch Dis Child 1984; 59: 578-80
9. Easton KL, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356-9
10. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a pediatric hospital. Br J Clin Pharmacol 1996; 42: 319-24
11. Thuermann P. Methods and systems to detect adverse drug reactions in hospital. Drug Saf 2001; 24: 961-8
12. Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000; 22: 161-8
13. Levy M, Azaz-Livshits T, Sadan B, et al. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999; 54: 887-92
14. Classen DC. Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847-51
15. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998; 280: 1317-20
16. Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding pediatric use. Br J Clin Pharmacol 1999; 48: 15-8
17. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in pediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000; 320: 79-82
18. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on pediatric wards: a prospective study. Acta Paediatr 1999; 88: 965-8
19. Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics 2002; 110: 254-7
20. Thuermann PA, Windecker R, Steffen J, et al. Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 2002; 25: 713-24
21. Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990; 11: 272-6
22. Edwards IR, Aronson JK. Adverse drug reactions definitions, diagnosis, and management. Lancet 2000; 356: 1255-9
23. BPI Service GmbH: Fach Info-Service (SPCs) Deutschland. Bundesverband der Pharmazeutischen Industrie [online]. Available from URL: http://www.fachinfo.de [Accessed 2004 Feb 24]
24. Thomson Corporation. Thomson Micromedex® Healthcare Series 2001, Vol. 108,2001 [online]. Available from URL: http://www.micromedex.com [Accessed 2004 Feb 24]
25. Schosser R, Quast U. Verdacht auf Nebenwirkungen: Medizinische Überlegungen zur Kausalität. Pharm Ind 1998; 60: 185-91
26. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM. editor. Textbook of adverse drug reactions. Oxford: Oxford University Press. 1991: 18-45
27. Vazquez de la Villa A, Luna del Castillo JD, Galdo Munoz G, et al. Adverse reactions caused by drugs in pediatrics [Spanish]. An Esp Pediatr 1989; 31: 49-53
28. Gonzalez-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients: a prospective study. Int J Clin Pharmacol Ther 1998; 36: 530-3
29. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681-8
30. Mitchell AA, Lacouture PG, Sheehan JE, et al. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24-9
31. Yosselson-Superstine S, Weiss T. Drug-related hospitalization in pediatric patients. J Clin Hosp Pharm 1982; 7: 195-203
32. McKenzie MW, Marchall GL, Netzloff ML, et al. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976; 89: 487-90
33. Bonati M, Marchetti F, Zullini MT, et al. Adverse drug reactions in neonatal intensive care units. Adverse Drug React Acute Poisoning Rev 1990; 9: 103-18
34. Aranda JV, Portuguez-Malavasi A, Collinge JM, et al. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 1982; 5: 173-84
35. Gill AM, Leach HJ, Hughes J, et al. Adverse drug reactions in a pediatric intensive care unit. Acta Paediatr 1995; 84: 438-41
36. Dharnidharka VR, Kandoth P. Pediatric inpatient morbidity patterns and drug usage in a teaching hospital serving an underdeveloped area. Indian J Public Health 1999; 43: 64-6
37. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114-20
38. Thomas EJ, Lipsitz SR, Studdert DM, et al. The reliability of medical record review for estimating adverse event rates. Ann Intern Med 2002; 136: 812-6
39. Kilbridge P. Computer crash -lessons from a system failure. N Engl J Med 2003; 348: 881-2
40. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol 2002; 54: 665-70
41. Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 1059-67
42. t'Jong GW, van der Linden PD, Bakker EM, et al. Unlicensed and off-label drug use in a pediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 2002; 58: 293-7
43. Andrews LB, Stocking C, Krizek T, et al. An alternative strategy for studying adverse events in medical care. Lancet 1997; 349: 309-13